A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery (NCT06664775)
An Open Label, Prospective, Randomized, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of TachoSil® Versus Surgicel™ Original (Oxidized Regenerated Cellulose) as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery.
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this clinical study is to assess the efficacy and safety of TachoSil compared to the widely known and used for \> 60 years local hemostatic product Surgicel Original as an adjunct to control mild to moderate soft tissue bleeding during surgery.
Who can join: Review the eligibility criteria below.
Location: Torrance Memorial — Torrance, California
Age range: 1 Month
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- Torrance Memorial — Torrance, California
- St. Anthony Hospital — Lakewood, Colorado
- Georgetown University — Washington D.C., District of Columbia
- University Of Chicago — Chicago, Illinois
- Indiana University — Indianapolis, Indiana
- University of Louisville — Louisville, Kentucky
- Washington University — St Louis, Missouri
- Atrium Health Carolinas Medical Center — Charlotte, North Carolina
- The Ohio State University Medical Center — Columbus, Ohio
📞 Contact the Study Coordinator
Phone: (416) 578-9058
Email: Jeff.wilson@corza.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hemorrhage
- Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy — Baltimore, Maryland
- Restarting Anticoagulation After Traumatic Intracranial Hemorrhage — Austin, Texas
- Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation — Denver, Colorado
- NIRS Monitoring in Premature Infants — Boston, Massachusetts
Explore by condition: All Hemorrhage clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.